KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Times Interest Earned: 2009-2025

Historic Times Interest Earned for Regeneron Pharmaceuticals (REGN) over the last 15 years, with Sep 2025 value amounting to $53.20.

  • Regeneron Pharmaceuticals' Times Interest Earned fell 37.75% to $53.20 in Q3 2025 from the same period last year, while for Sep 2025 it was $87.61, marking a year-over-year increase of 38.90%. This contributed to the annual value of $72.30 for FY2024, which is 30.40% up from last year.
  • Per Regeneron Pharmaceuticals' latest filing, its Times Interest Earned stood at $53.20 for Q3 2025, which was down 82.26% from $299.86 recorded in Q2 2025.
  • Regeneron Pharmaceuticals' 5-year Times Interest Earned high stood at $299.86 for Q2 2025, and its period low was $46.67 during Q1 2024.
  • Moreover, its 3-year median value for Times Interest Earned was $62.42 (2023), whereas its average is $85.61.
  • In the last 5 years, Regeneron Pharmaceuticals' Times Interest Earned tumbled by 64.80% in 2022 and then surged by 314.92% in 2025.
  • Quarterly analysis of 5 years shows Regeneron Pharmaceuticals' Times Interest Earned stood at $187.21 in 2021, then plummeted by 64.80% to $65.91 in 2022, then decreased by 19.34% to $53.16 in 2023, then soared by 77.38% to $94.30 in 2024, then slumped by 37.75% to $53.20 in 2025.
  • Its last three reported values are $53.20 in Q3 2025, $299.86 for Q2 2025, and $68.01 during Q1 2025.